GlassScriptPhysician profile
Maren E Bahra
NPI 1730646696
$1,261.89
in general payments reported to CMS, 2019-2025
16 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.02 · 2022: $219 · 2024: $20.98 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.58 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $243.73 | 2025 | |
| Stryker Corporation | $178.09 | 2022 | |
| Ucb, INC. | $162.49 | 2025 | Bimzelx |
| Janssen Biotech, INC. | $120.03 | 2025 | Tremfya |
| Amgen INC. | $79.14 | 2025 | Otezla |
| Galderma Laboratories, L.P. | $78.38 | 2025 | Nemluvio |
| Organon LLC | $72.50 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $68.99 | 2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $67.18 | 2025 | |
| Abbvie INC. | $46.36 | 2024-2025 | |
| Leo Pharma INC. | $31.75 | 2025 | Adbry |
| Boston Scientific Corporation | $28.76 | 2022 | |
| Pinnacle, INC | $28.47 | 2021-2022 | |
| Convatec INC. | $25.92 | 2025 | |
| Botanix Sb INC | $15.53 | 2025 | Sofdra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $14.57 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maren Bahra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.